随着“十五五”规划建议出炉，为中国医药行业锚定了“创新驱动、自主可控、普惠可及”的发展航向。站在这一历史性发展节点，政策引导与产业升级形成强劲共振，需求刚性与供给革新构筑行业发展核心逻辑。随着医保支付体系优化、创新生态完善、国际化进程提速，医药行业正告别规模扩张的传统模式，迈入高质量发展的新周期。从资本市场视角看，创新药、医疗器械、中药、 原料药、医疗服务等细分领域机遇凸显，有望在政策红利与...
Source Link随着“十五五”规划建议出炉，为中国医药行业锚定了“创新驱动、自主可控、普惠可及”的发展航向。站在这一历史性发展节点，政策引导与产业升级形成强劲共振，需求刚性与供给革新构筑行业发展核心逻辑。随着医保支付体系优化、创新生态完善、国际化进程提速，医药行业正告别规模扩张的传统模式，迈入高质量发展的新周期。从资本市场视角看，创新药、医疗器械、中药、 原料药、医疗服务等细分领域机遇凸显，有望在政策红利与...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.